Veeva Systems has announced Veeva Falcon Safety, an agentic safety operations product to streamline adverse event intake, case processing, and follow-up to reduce costs, increase speed, and maintain compliance for biopharma companies of all sizes.
In addition to working seamlessly with Veeva Safety, Falcon Safety will provide intake and follow-up management for any E2B-compliant safety system, including Oracle Argus and ArisGlobal LifeSphere MultiVigilance.
"We've had the privilege of working closely with case processors, pharmacovigilance experts, and safety specialists globally to build Veeva Safety," said Marius Mortensen, vice president of product, Falcon at Veeva. "With Falcon Safety, we're excited to build on that partnership to help the industry reinvent safety operations."
Planned for early adopter availability in November 2026, Falcon Safety is part of Veeva AI, Veeva's industry-specific AI solutions for life sciences. The product is designed to support biopharma companies of all sizes across any intake channels, addressing the critical need for efficient adverse event management while maintaining regulatory compliance in the evolving pharmacovigilance landscape.
Veeva Systems delivers the industry cloud for life sciences with applications, agents, data, and consulting. The introduction of Falcon Safety extends Veeva's commitment to innovation and product excellence, providing agentic AI capabilities that transform traditional safety operations into streamlined, intelligent workflows.
About Veeva Systems
Veeva delivers the industry cloud for life sciences with applications, agents, data, and consulting. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,500 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves.
